Dynavox Group

DYVOX · Nasdaq Stockholm · Healthcare

77.65SEK +1.4%last day

Price as of 2 October 2026

The price over the past year, with dividends: −31.7%

Performance

1 month

−0.3%

1 year

−31.7%

3 years, per year

+37.5%

5 years, per year

–

Largest fall, 3 years

−55.5%

Below the peak now

−40.5%

Volatility, 1 year

44.8%

Return with dividends reinvested.

Key figures

P/E

35.3

P/B

11.2

Dividend yield

0.6%

Return on equity

+31.7%

Net margin

+8.9%

Market value

824 m USD

Quality, value and trend

Where Dynavox Group stands against every Nordic stock today. 100 is best.

Quality67

Profitability and a sound balance sheet over time. Better than 67% of Nordic stocks.

Value19

The price measured against earnings, assets and cash flow. Better than 19% of Nordic stocks.

Trend45

The price development over the past year. Better than 45% of Nordic stocks.

Combined35

Quality, value and trend together. Better than 35% of Nordic stocks.

About Dynavox Group

Dynavox Group is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 1,100 employees.

Dynavox Group AB (publ), through its subsidiaries, engages in the development and sale of assistive technology products for customers with communication disabilities. The company offers custom designed augmentative and alternative communication (AAC) solutions that enable people with disabilities, such as cerebral palsy, ALS, autism, and spinal cord injury, to communicate on their own. Its communication solutions include language, software, hardware, funding, support, and training. The company operates in Sweden, Norway, Denmark, Belgium, the United States, Germany, France, China, the United Kingdom, Ireland, Australia, and New Zealand.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis